Verition Fund Management
BSX icon

Verition Fund Management’s Boston Scientific BSX Stock Holding History

Verition Fund Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-13,600
Closed -$1.3M – 2403
2025
Q4 		$1.3M Sell
13,600
-44,900
-77% -$4.4M 0.01% 1954
2025
Q3 		$5.71M Buy
58,500
+12,500
+27% +$1.29M 0.02% 1008
2025
Q2 		$4.94M Buy
46,000
+11,800
+35% +$1.19M 0.02% 1129
2025
Q1 		$3.45M Sell
34,200
-5,300
-13% -$534K 0.02% 1151
2024
Q4 		$3.53M Sell
39,500
-400
-1% -$35.2K 0.01% 1152
2024
Q3 		$3.34M Hold
39,900
– – 0.02% 1117
2024
Q2 		$3.07M Buy
39,900
+5,400
+16% +$395K 0.02% 1029
2024
Q1 		$2.36M Buy
+34,500
New +$2.22M 0.02% 1116
2022
Q4 		– Sell
-14,000
Closed -$542K – 2189
2022
Q3 		$542K Buy
+14,000
New +$562K 0.01% 1842
2022
Q2 		– Sell
-38,200
Closed -$1.69M – 2398
2022
Q1 		$1.69M Buy
38,200
+21,000
+122% +$910K 0.02% 1088
2021
Q4 		$731K Buy
+17,200
New +$723K 0.01% 1492

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Verition Fund Management's BSX Position: Q2 2026 in Review

Verition Fund Management increased its Boston Scientific (BSX) stake by 330% in Q2 2026, buying an estimated $17.1M and bringing the position to 410,164 shares worth $17.5M. The position accounts for 0.09% of the portfolio, ranked #231.

Verition Fund Management first reported a position in BSX in Q3 2013 and has held it in 36 quarters since. The position peaked at $33.8M in Q1 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Verition Fund Management held 410,164 shares of Boston Scientific worth $17.5M as of Q2 2026.
  • Verition Fund Management bought 314,789 Boston Scientific shares in Q2 2026, an estimated $17.1M.
  • Boston Scientific made up 0.09% of Verition Fund Management's portfolio in Q2 2026, its #231 holding.
  • Verition Fund Management first reported a position in Boston Scientific in Q3 2013 and has held it in 36 quarters since.
  • Verition Fund Management's Boston Scientific position peaked at $33.8M in Q1 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.